Tag: Centenary Institute

The Centenary Institute has received funding from the RT Hall Trust to propel two pioneering cancer research projects. 

Researchers from the Centenary Institute and the University of Sydney have made a breakthrough in vaccine science by uncovering new insights into delta inulin, a crucial vaccine component.

Researchers from the Centenary Institute and the University of Technology Sydney have revealed a surprising connection between the Toll-like receptor 7 (TLR7) protein, typically recognised for its antiviral defense function, and the exacerbation of lung conditions, particularly chronic obstructive pulmonary disease (COPD).

Researchers at the Centenary Institute have identified a potential breakthrough in the treatment of hepatocellular carcinoma (HCC), the most prevalent form of liver cancer and the third leading cause of cancer-related deaths worldwide.